BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

First GMP Production at 24,000L Line of MFG5 Facility Successfully Completed at WuXi Biologics

WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has successf...

November 26, 2021 | News

Aopeng Medical Completes Clinical Trial of Robotic-Assisted Peripheral artery Intervention of iliac artery in human

The endovascular intervention surgical robot, combined with Digital Subtraction Angiography (DSA), precisely evaluated the target lesion and its location, ...

November 25, 2021 | News

Hetero and Shenzhen Beimei Pharmaceuticals launch antiviral drug Oselavir® in China

Hetero, a globally renowned vertically integrated pharmaceutical organization and Shenzhen Beimei Pharmaceuticals jointly announced that they have received...

November 12, 2021 | News

Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China

The more than 30,000 square meter property contains a comprehensive factory building on 5 floors, a demo workshop and a large warehouse including a state-o...

November 09, 2021 | News

China to Position Taizhou as a famous Chinese Medical City

It will build a platform for international exchanges and cooperation in the pharmaceutical and general health industries to further gather innovative...

November 05, 2021 | News

WuXi Biologics Launches a New GMP Commercial Drug Product Facility

Enhances drug product services for projects at various stages, with an emphasis on late and commercial stage production Increases up to 60 million vials...

November 01, 2021 | News

WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote G...

October 28, 2021 | News

China to Accelerate Innovations in Chronic Disease Management

The agreement will allow 111 and Chugai Pharma China to work together towards building a "Healthy China" by establishing a "SMART Healthcare City" concept ...

October 26, 2021 | News

Chinese BioPharma I-Mab Expands U.S. Footprint with New R&D Site

I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel bi...

October 25, 2021 | News

Columbia opens its third and largest hospital in Jiaxing, China

Jiaxing Kaiyi Hospital is licensed for 500 beds with a construction area of 112,000 square meters. It is built in accordance to Joint Commission Inte...

October 25, 2021 | News

International Biopharma Industry Week Shanghai 2021 Opens

Under the guidance of the Shanghai Biomedical Industry Development Leading Group, the inaugural International Biopharma Industry Week Shanghai (IBIWS) is...

October 15, 2021 | News

Chinese Researcher Releases Latest Research Results on Early Screening for Multiple Cancers

Berry Oncology, a Chinese oncology genomic testing company, was invited to the inaugural International Biopharma Industry Week in Shanghai (IBIWS...

October 14, 2021 | News

Winhealth-CARD Cooperation Boosts Rare Disease Healthy Ecosystem Construction

The cooperation involved rare disease registration and research, development of single disease diagnosis and treatment guidelines and regulations, doctor t...

October 12, 2021 | News

China sets ambitious biomedical goals with support of key companies

The annual business revenue of the biomedical industry in Binhai is expected to reach 100 billion yuan ($15.44 billion) by 2025 with the ...

October 01, 2021 | News

Stay Connected